Wanbang Pharmaceutical Holding Group (002082.SZ): The phase II/III clinical trial of Shishanjian Jia controlled release tablets has enrolled 100 subjects.

16:26 01/02/2026

Wanbangde (002082.SZ) announced that its wholly-owned subsidiary, Wanbangde Pharmaceutical Group Co., Ltd., has completed the enrollment of 100 subjects in the Phase II/III pivotal registration clinical trial for its new drug paclitaxel methoxycarbamoyl sustained-release tablets for the treatment of mild to moderate Alzheimer's disease dementia.

Wanbangde Pharmaceutical Holding Group (002082.SZ) announced that its wholly-owned subsidiary, Wanbangde Pharmaceutical Holding Group Pharmaceutical Group Co., Ltd., has completed the enrollment of 100 subjects for the phase II/III pivotal registration clinical trial of its new drug Shishang alkaloid methyl controlled-release tablets for the treatment of mild to moderate Alzheimer's disease dementia. Shishang alkaloid methyl is a cholinesterase inhibitor used to improve cognitive function. Preclinical studies have shown its potential to delay the progression of Alzheimer's disease, with a wide range of comprehensive benefits including reduction of beta-amyloid protein, anti-inflammatory, antioxidant stress, and neuroprotective effects. It is expected to become a drug with broad-spectrum anti-Alzheimer's disease dementia properties. The company is actively enrolling subjects and will continue to work closely with over 50 national research institutions including the Xuanwu Hospital of Capital Medical University to further verify the safety and efficacy of the drug, providing crucial data support for the final market approval application.

LI AUTO delivered 27,668 new vehicles in January, a year-on-year decrease of 7.5%.

Geely Auto (00175) sold a total of 270,200 vehicles in January, an increase of approximately 1% year-on-year.

SF INTRA-CITY (09699) released a profit announcement, expecting that the annual profit attributable to shareholders in 2025 will increase by no less than 80% compared to the previous year.

LI AUTO delivered 27,668 new vehicles in January, a year-on-year decrease of 7.5%.

Geely Auto (00175) sold a total of 270,200 vehicles in January, an increase of approximately 1% year-on-year.

SF INTRA-CITY (09699) released a profit announcement, expecting that the annual profit attributable to shareholders in 2025 will increase by no less than 80% compared to the previous year.